Orexigen Therapeutics investor buys 650,000 shares for 7.5% interest

By Lisa Kerner

Charlotte, N.C., Dec. 3 - A group of Orexigen Therapeutics, Inc. shareholders led by Domain Partners VII, LP bought 650,000 shares of the company's stock between Nov. 10 and Nov. 24 priced from $6.75 to $6.93 each, according to a schedule 13D/A filed with the Securities and Exchange Commission on Thursday.

Domain beneficially owns 3,543,832 shares, or 7.5%, of the San Diego biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.